These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 32341177

  • 1. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
    Singal D, Chateau D, Struck S, Lee JB, Dahl M, Derksen S, Katz LY, Ruth C, Hanlon-Dearman A, Brownell M.
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32341177
    [Abstract] [Full Text] [Related]

  • 2. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 3. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 4. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A, Mahic M, Handal M, Ystrom E, Reichborn-Kjennerud T, Nordeng H.
    BJOG; 2021 Nov 01; 128(12):1917-1927. PubMed ID: 33982858
    [Abstract] [Full Text] [Related]

  • 5. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L, Slack-Smith L, Stanley FJ, Bower C.
    CNS Drugs; 2012 Jul 01; 26(7):e1-14. PubMed ID: 22712699
    [Abstract] [Full Text] [Related]

  • 6. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
    Ames JL, Ladd-Acosta C, Fallin MD, Qian Y, Schieve LA, DiGuiseppi C, Lee LC, Kasten EP, Zhou G, Pinto-Martin J, Howerton EM, Eaton CL, Croen LA.
    Biol Psychiatry; 2021 Aug 15; 90(4):253-262. PubMed ID: 34116791
    [Abstract] [Full Text] [Related]

  • 7. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I.
    Am J Obstet Gynecol; 2019 Jan 15; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [Abstract] [Full Text] [Related]

  • 8. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC, Meltzer-Brody S, Woolson S, Hamer RM, Smith JK, Lury K, Gilmore JH.
    Neuropsychopharmacology; 2014 Oct 15; 39(11):2611-21. PubMed ID: 24837031
    [Abstract] [Full Text] [Related]

  • 9. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D, Tiemeier H, Stricker BH, Muetzel RL, Hillegers M, El Marroun H.
    JAMA Psychiatry; 2023 Dec 01; 80(12):1208-1217. PubMed ID: 37647036
    [Abstract] [Full Text] [Related]

  • 10. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.
    Ann Epidemiol; 2013 Nov 01; 23(11):681-7. PubMed ID: 24113367
    [Abstract] [Full Text] [Related]

  • 11. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
    Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.
    BJOG; 2016 Nov 01; 123(12):1908-1917. PubMed ID: 26374234
    [Abstract] [Full Text] [Related]

  • 12. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N, Oberlander TF.
    Birth Defects Res; 2017 Jul 17; 109(12):909-923. PubMed ID: 28714603
    [Abstract] [Full Text] [Related]

  • 13. Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.
    Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M.
    BJOG; 2014 Dec 17; 121(13):1621-31. PubMed ID: 24726047
    [Abstract] [Full Text] [Related]

  • 14. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.
    Upadhyaya S, Brown A, Cheslack-Postava K, Gissler M, Gyllenberg D, Heinonen E, Laitinen J, McKeague I, Hinkka-Yli-Salomäki S, Sourander A, Tornio A, Malm H.
    Reprod Toxicol; 2023 Jun 17; 118():108365. PubMed ID: 36958464
    [Abstract] [Full Text] [Related]

  • 15. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 17; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 16. Antidepressant use during pregnancy and asthma in the offspring.
    Liu X, Olsen J, Pedersen LH, Agerbo E, Yuan W, Li J.
    Pediatrics; 2015 Apr 17; 135(4):e911-7. PubMed ID: 25755245
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun 17; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 18. Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?
    Pedersen LH.
    Paediatr Drugs; 2015 Dec 17; 17(6):443-8. PubMed ID: 26092083
    [Abstract] [Full Text] [Related]

  • 19. Prenatal exposure to selective serotonin reuptake inhibitors and autistic symptoms in young children: another red herring?
    Petersen I, Evans S, Nazareth I.
    Br J Psychiatry; 2014 Aug 17; 205(2):105-6. PubMed ID: 25252319
    [Abstract] [Full Text] [Related]

  • 20. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
    Malm H, Artama M, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague I, Sourander A.
    BMC Psychiatry; 2012 Dec 04; 12():217. PubMed ID: 23206294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.